In this issue:
JAVELIN Bladder 100 shows avelumab maintenance confers survival advantage in UC
Patterns of metastases of prostatic ductal adenocarcinoma
Atezolizumab use in patients with autoimmune disease
Defects in DNA repair genes confer improved long-term survival after cisplatin-based NAC for MIBC
Preoperative frailty predicts poorer outcome following cystectomy
Efficacy of bladder-preserving treatments for NMIBC following intravesical Bacillus Calmette-Guérin
Combination brachytherapy, external beam radiotherapy and ADT for very high-risk prostate cancer
Faecal microbiota transplantation for TKI-induced diarrhoea
No survival advantage with durvalumab over chemotherapy in metastatic UC
Olaparib improves survival in castration-resistant prostate cancer with impaired DNA repair genes
Please login below to download this issue (PDF)